Product

Company

NCT01385111·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Cancer Center, Korea

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Histologically confirmed or strongly suspected non-small cell lung cancer (NSCLC)
Potentially operable patients

M1 disease
Inoperable T4 disease
Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible on chest CT.
Confirmed supraclavicular lymph node metastasis
Pancoast tumors
Medically inoperable patients
Contraindications for bronchoscopy and esophageal endoscopy
Drug reaction to lidocaine, midazolam,fentanyl
Pregnancy
Ground glass-dominant nodule ( \< 3cm)

The record

StatusCompleted

PhaseNo phase

Taking part162

StartedJun 2011

UpdatedOct 18, 2012

Conditions

Where1

Clareo Health | Combined Application of EBUS and EUS in Lung Cancer